States / U.S. Congress / HRES 803
HRES 803 In Committee
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
No summary has been published for this bill. The full text is on the Bill text tab.
- Chamber
- House
- Introduced
- Oct 10, 2025
- Last action
- Oct 10, 2025 — Submitted in House
- Session
- 119
- Momentum
- 45 · Moderate